Appropriateness of antibiotic treatment of acute respiratory tract infections in Tunisian primary care and emergency departments: a multicenter cross-sectional study.
Acute respiratory tract infections
Antibiotics
Appropriateness
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
22 11 2022
22 11 2022
Historique:
received:
28
10
2021
accepted:
13
07
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
Little is known about the pattern and appropriateness of antibiotic prescriptions in patients with acute respiratory tract infections (ARTIs). Describe the antibiotics used to treat ARTIs in Tunisian primary care offices and emergency departments (EDs), and assess the appropriateness of their use. It was a prospective multicenter cross-sectional observational clinical study conducted at 63 primary care offices and 6 EDS during a period of 8 months. Appropriateness of antibiotic prescription was evaluated by trained physicians using the medication appropriateness index (MAI). The MAI ratings generated a weighted score of 0 to 18 with higher scores indicating low appropriateness. The study was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study was approved by the Ethics committee of Monastir Medical Faculty. From the 12,880 patients screened we included 9886 patients. The mean age was 47.4, and 55.4% were men. The most frequent diagnosis of ARTI was were acute bronchitis (45.3%), COPD exacerbation (16.3%), tonsillitis (14.6%), rhinopharyngitis (12.2%) and sinusitis (11.5%). The most prescribed classes of antibiotics were penicillins (58.3%), fluoroquinolones (17.6%), and macrolides (16.9%). Antibiotic therapy was inappropriate in 75.5% of patients of whom 65.2% had bronchitis. 65% of patients had one or more antibiotic prescribing inappropriateness criteria as assessed by the MAI. The most frequently rated criteria were with expensiveness (75.8%) and indication (40%). Amoxicillin-clavulanic acid and levofloxacin were the most inappropriately prescribed antibiotics. History of cardiac ischemia ([OR] 3.66; 95% [CI] 2.17-10.26; p < 0.001), asthma ([OR] 3.29, 95% [CI] 1.77-6.13; p < 0.001), diabetes ([OR] 2.09, 95% [CI] 1.54-2.97; p = 0.003), history of COPD ([OR] 1.75, 95% [CI] 1.43-2.15; p < 0.001) and age > 65 years (Odds Ratio [OR] 1.35, 95% confidence interval [CI] 1.16-1.58; p < 0.001) were associated with a higher likelihood of inappropriate prescribing. Our findings indicate a high inappropriate use of antibiotics in ARTIs treated in in primary care and EDs. This was mostly related to antibiotic prescription in acute bronchitis and overuse of expensive broad spectrum antibiotics. Future interventions to improve antibiotic prescribing in primary care and EDs is needed. the trial is registered at Clinicaltrials.gov registry (NCT04482231).
Sections du résumé
BACKGROUND
Little is known about the pattern and appropriateness of antibiotic prescriptions in patients with acute respiratory tract infections (ARTIs).
OBJECTIVE
Describe the antibiotics used to treat ARTIs in Tunisian primary care offices and emergency departments (EDs), and assess the appropriateness of their use.
METHODS
It was a prospective multicenter cross-sectional observational clinical study conducted at 63 primary care offices and 6 EDS during a period of 8 months. Appropriateness of antibiotic prescription was evaluated by trained physicians using the medication appropriateness index (MAI). The MAI ratings generated a weighted score of 0 to 18 with higher scores indicating low appropriateness. The study was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study was approved by the Ethics committee of Monastir Medical Faculty.
RESULTS
From the 12,880 patients screened we included 9886 patients. The mean age was 47.4, and 55.4% were men. The most frequent diagnosis of ARTI was were acute bronchitis (45.3%), COPD exacerbation (16.3%), tonsillitis (14.6%), rhinopharyngitis (12.2%) and sinusitis (11.5%). The most prescribed classes of antibiotics were penicillins (58.3%), fluoroquinolones (17.6%), and macrolides (16.9%). Antibiotic therapy was inappropriate in 75.5% of patients of whom 65.2% had bronchitis. 65% of patients had one or more antibiotic prescribing inappropriateness criteria as assessed by the MAI. The most frequently rated criteria were with expensiveness (75.8%) and indication (40%). Amoxicillin-clavulanic acid and levofloxacin were the most inappropriately prescribed antibiotics. History of cardiac ischemia ([OR] 3.66; 95% [CI] 2.17-10.26; p < 0.001), asthma ([OR] 3.29, 95% [CI] 1.77-6.13; p < 0.001), diabetes ([OR] 2.09, 95% [CI] 1.54-2.97; p = 0.003), history of COPD ([OR] 1.75, 95% [CI] 1.43-2.15; p < 0.001) and age > 65 years (Odds Ratio [OR] 1.35, 95% confidence interval [CI] 1.16-1.58; p < 0.001) were associated with a higher likelihood of inappropriate prescribing.
CONCLUSION
Our findings indicate a high inappropriate use of antibiotics in ARTIs treated in in primary care and EDs. This was mostly related to antibiotic prescription in acute bronchitis and overuse of expensive broad spectrum antibiotics. Future interventions to improve antibiotic prescribing in primary care and EDs is needed.
TRIAL REGISTRATION
the trial is registered at Clinicaltrials.gov registry (NCT04482231).
Identifiants
pubmed: 36418965
doi: 10.1186/s12875-022-01904-7
pii: 10.1186/s12875-022-01904-7
pmc: PMC9682766
doi:
Substances chimiques
Anti-Bacterial Agents
0
Banques de données
ClinicalTrials.gov
['NCT04482231']
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
295Informations de copyright
© 2022. The Author(s).
Références
BMJ. 2009 Jun 23;338:b2242
pubmed: 19549995
Eur J Clin Pharmacol. 2016 Mar;72(3):359-64
pubmed: 26706249
Clin Infect Dis. 2001 Sep 15;33(6):757-62
pubmed: 11512079
Drugs Aging. 2013 Nov;30(11):893-900
pubmed: 24062215
Fam Pract. 2015 Aug;32(4):401-7
pubmed: 25911505
J Antimicrob Chemother. 2017 Jan;72(1):305-310
pubmed: 27624570
Clin Microbiol Infect. 2014 Oct;20(10):973-80
pubmed: 25273968
BMJ. 2014 Sep 23;349:g5493
pubmed: 25249162
Int J Infect Dis. 2016 Nov;52:16-22
pubmed: 27639454
Int J Infect Dis. 2017 Feb;55:20-23
pubmed: 27955991
Fam Med. 2006 May;38(5):349-54
pubmed: 16673197
JAMA Intern Med. 2013 Feb 25;173(4):273-5
pubmed: 23318503
Eur J Clin Pharmacol. 2005 Nov;61(10):769-73
pubmed: 16200422
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29967028
J Hosp Med. 2016 Mar;11(3):174-80
pubmed: 26443327
BMJ. 2008 Jul 23;337:a437
pubmed: 18650239
J Antimicrob Chemother. 2014 Jan;69(1):234-40
pubmed: 23887867
J Antimicrob Chemother. 2005 Nov;56(5):930-6
pubmed: 16155062
BMJ Qual Saf. 2011 Mar 21;20(9):764-772
pubmed: 21441602
Scand J Prim Health Care. 2015;33(4):269-74
pubmed: 26683287
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
J Eval Clin Pract. 2011 Dec;17(6):1176-83
pubmed: 20586844
Antimicrob Agents Chemother. 2014;58(3):1451-7
pubmed: 24342652
Scand J Prim Health Care. 2017 Mar;35(1):10-18
pubmed: 28277045
J Clin Epidemiol. 1992 Oct;45(10):1045-51
pubmed: 1474400
PLoS One. 2017 Feb 7;12(2):e0171284
pubmed: 28170413
Ann Pharmacother. 1997 May;31(5):543-8
pubmed: 9161645
BMJ Open. 2014 Oct 27;4(10):e006245
pubmed: 25348424
Fam Pract. 2019 Jul 31;36(4):402-409
pubmed: 30272148